focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,748.50
Bid: 2,175.00
Ask: 1,450.00
Change: -64.00 (-3.53%)
Spread: -725.00 (-33.333%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks Rebound; RSA Surges On Zurich's Interest

Tue, 28th Jul 2015 16:00

LONDON (Alliance News) - UK shares ended higher Tuesday, together with other major European equities markets, while the pound strengthened against the dollar following a reassuring reading of second quarter UK GDP.

On the corporate front, RSA Insurance shares surged after Switzerland's Zurich Insurance confirmed it is evaluating a potential offer for the FTSE 100 company. At the other end of the table, Royal Mail led the blue-chip losers after UK regulator Ofcom said its provisional view is that the postal company breached competition law in its wholesale pricing to competitors.

The FTSE 100 closed up 0.8% at 6,555.28, taking back about half of Monday's losses. The FTSE 250 ended up 0.7% at 17,387.89, and the AIM All-Share index finished up 0.2% at 749.16.

European major indices also improved, with the CAC 40 in Paris adding 1.0% and the DAX 30 in Frankfurt climbing 1.1%.

The pound rose sharply against other major currencies following UK GDP data, which came in as expected, coming off session lows of USD1.5526 against the dollar.

The UK economy expanded at a faster pace in the second quarter, largely driven by an improvement in services output, a preliminary estimate from the Office for National Statistics showed. Gross domestic product grew 0.7% quarter-on-quarter, in line with forecasts, following a 0.4% rise in the first quarter.

Services expanded 0.7% and production increased 1%. Construction growth came in flat, and agriculture contracted 0.7%. UK GDP was 2.6% higher in the second quarter compared with the same quarter a year ago. The annual growth figure also matched expectations.

After the UK GDP release, better-than-expected readings from the US Markit services and composite purchasing managers' indices weren't enough to pull the dollar back up against the pound. Sterling remained higher against the greenback after subsequent disappointing US consumer confidence data.

Confidence among US consumers saw a substantial deterioration in the month of July, according to a report released by the US Conference Board. The US Conference Board said its consumer confidence index tumbled to 90.9 in July from a downwardly revised 99.8 in June. Economists had expected the index to show a much more modest decrease to a reading of 99.6 from the 101.4 originally reported for the previous month.

Markit services PMI came in at 55.2 for the US, slightly above economist expectations for a 55.0 reading, and also above the 54.8 reading seen in June. The composite index also read 55.2, ahead of the 54.6 level a month ago.

At the European stock markets close, the pound was trading at USD1.5597, slightly up from USD1.5577 at Monday's equities close in London.

The US Federal Open Market Committee begins on Tuesday its two-day meeting ahead of its interest rate announcement on Wednesday at 1900 BST.

The Fed is widely expected to leave US interest rates unchanged at the meeting. However, investors will pay attention to the accompanying monetary policy statement, after a recent hawkish speech and Congressional testimony by Fed Chair Janet Yellen intensified expectations that the bank would hike rates later this year.

Many analysts still expect the Fed to raise US interest rates at its next meeting in September and will be closely scrutinizing the statement for any hints about the timing of the first US rate hike in nine years.

At the European equity markets close, Wall Street was higher, with the Dow 30 up 0.6%, the S&P 500 up 0.7%, and the Nasdaq Composite up 0.4%. In a busy day in the US earnings calendar, online social networking service Twitter, biotechnology company Gilead Sciences, and online business review site Yelp are yet expected to release updates after the New York market close.

On the London Stock Exchange, RSA Insurance was the best performer in the FTSE 100, up 16%, after Zurich Insurance said it is evaluating a potential bid for RSA. After the Swiss insurer's announcement early Tuesday, RSA said it has not held talks or received any offer from its European peer. Zurich had said its announcement does not represent a firm offer to buy RSA and said there is no assurance that any offer will be made.

Following Zurich's statement, Shore Capital upgraded its rating on RSA Insurance Group to Buy from Hold. Shore analyst Eamonn Flanagan said that despite the group's recent problems there are some "terrific assets" in RSA which would be attractive to potential buyers. In addition, following the rights issue and disposals, the analyst said the group is pretty well capitalised.

Hikma Pharmaceuticals ended up 12% at 2,327.80 pence, after it said it has agreed a USD2.65 billion deal to acquire Roxane Laboratories and Boehringer Ingelheim Roxane from Boehringer Ingelheim, the German pharmaceutical company. Under the terms of the deal, Hikma will issue 40 million shares to Boehringer at 2,350 pence per share, along with a USD1.18 billion cash payment. This will give Boehringer an around 16.71% interest in the company.

Hikma said that Boehringer's investment in Hikma's shares at a premium reflected Boehringer's confidence in the value creation potential for them as long-term shareholders.

GKN closed up 6.5%. The engineer said it has agreed a EUR706 million deal to acquire Netherlands-based Fokker Technologies Group, while reporting a fall in pretax profit for the first half of 2015 thanks to weakness in some of its key end markets. GKN said it will pay EUR706 million to acquire Fokker Technologies, a Dutch maker of aerostructures, electrical wiring systems, landing gear and associated services. GKN said the deal will strengthen its position in the aerospace market and will expand its presence in the Chinese, Turkish, Indian and Mexican markets.

News of the acquisition eclipsed any concerns about GKN's first-half results. GKN's pretax profit for the six months to the end of June was down to GBP212 million from GBP224 million a year earlier, despite an increase in sales for the group to GBP3.62 billion from GBP3.57 billion.

Meanwhile, Royal Mail ended down 3.4% after UK media and communications regulator Ofcom said it has issued a statement of objections to the postal service operator, with a provisional view that the company breached competition law by discriminating in its wholesale pricing against postal operators that competed with it on delivery.

Ofcom said its provisional findings, part of the investigation launched following a complaint by Whistl, a former competitor of Royal Mail, are that Royal Mail's changes to prices, terms and conditions for the provision of access services included "unlawful price discrimination".

In response, Royal Mail said it was "disappointed" by the regulator's announcement and added it takes its compliance obligations "very seriously".

In the FTSE 250, Melrose Industries closed up 9.7% after it said it sold its Elster business to US industrial conglomerate Honeywell International for GBP3.3 billion in cash. It said that in addition to the cash consideration, Honeywell will assume the majority of the pension schemes on Melrose's books.

Melrose is planning to use the consideration for the Elster businesses to return more than GBP2 billion to its shareholders and for general corporate purposes, including paying down its debt obligations.

In a very busy corporate calendar Wednesday, among others, Sky releases full-year results and Barclays, Capita, Taylor Wimpey, St James's Place and British American Tobacco publish half-year results. Antofagasta issues a second-quarter production report, while Compass Group and Brewin Dolphin release interim management statements. GlaxoSmithKline releases its second-quarter results at 1200 BST.

In the economic calendar, the German Gfk consumer confidence survey is due at 0700 BST, while UK consumer credit and mortgage approvals data are due at 0930 BST. In the US, pending home sales are due at 1500 BST, while EIA Crude Oil stocks are at 1530 BST.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more
24 Apr 2024 14:19

UK earnings, trading statements calendar - next 7 days

Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
Loungers PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
Tuesday 30 April 
Avacta Group PLCFull Year Results
Card Factory PLCFull Year Results
Capital & Regional PLCFull Year Results
Close Brothers Group PLCTrading Statement
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCHalf Year Results
Fadel Partners IncFull Year Results
Glencore PLCTrading Statement
Hargreaves Lansdown PLC Trading Statement
Howden Joinery PLCTrading Statement
HSBC Holdings PLCQ1 Results
Kelso Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Phoenix Spree Deutschland LtdFull Year Results
RBG Holdings PLCFull Year Results
Rotork PLCTrading Statement
Safestore Holdings PLCHalf Year Results
Shield Therapeutics PLCFull Year Results
St James's Place PLCTrading Statement
Strip Tinning Holdings PLCFull Year Results
Whitbread PLCFull Year Results
Wednesday 1 May 
Computacenter PLCTrading Statement
GSK PLCQ1 Results
Haleon PLCTrading Statement
HSS Hire Group PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Maintel Holdings PLCFull Year Results
Next PLCTrading Statement
Smith & Nephew PLCTrading Statement
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
24 Apr 2024 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.

Read more
24 Apr 2024 09:14

GSK's Jemperli with chemotherapy accepted for priority review by FDA

(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jemperli, when used in combination with chemotherapy.

Read more
17 Apr 2024 08:46

TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment

(Alliance News) - GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a form of gonorrhoea.

Read more
17 Apr 2024 07:11

GSK posts promising results from gonorrhoea treatment trial

(Sharecast News) - GSK unveiled encouraging outcomes from a pivotal phase three trial on Wednesday, on the potential of gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea (GC), amid escalating resistance to current therapies.

Read more
16 Apr 2024 09:17

GSK meningococcal vaccine accepted by US FDA for review

(Sharecast News) - GSK announced on Tuesday that its five-in-one meningococcal ABCWY (MenABCWY) vaccine candidate had been accepted for regulatory review by the US Food and Drug Administration (FDA).

Read more
16 Apr 2024 08:59

GSK's latest meningitis vaccine accepted for review by US regulator

(Alliance News) - GSK PLC on Tuesday said it has made progress in the development of its newest candidate, which combines the strengths of two other vaccines in its portfolio into one bacteria-fighting inoculation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.